Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tango Therapeutics, Inc. | 8,198,642 | reported | 16 Oct 2023 | tx 2+1,250,000 |
| Tyra Biosciences, Inc. | 6,448,359 | reported | 17 Dec 2021 | tx 1+125,000 |
| Odonate Therapeutics, Inc. | 5,607,086 | reported | 30 Dec 2020 | tx 3+400,000 |
| Mirati Therapeutics, Inc. | 1,565,560 | reported | 07 Jun 2018 | tx 7+461,016−1,269,453 |
| Esperion Therapeutics, Inc. |
| 1,119,860 |
| reported |
| 05 Nov 2018 |
| tx 8−100,000 |
| Rain Therapeutics Inc. | 79,726 | reported | 27 Apr 2021 | tx 5+4,197,489−3,263,986 |
| iTeos Therapeutics, Inc. | 72,243 | reported | 28 Jul 2020 | tx 6+4,417,259−9,751,773 |
| PMV Pharmaceuticals, Inc. | 32,708 | reported | 29 Sept 2020 | tx 9+2,329,073−1,379,073 |
| Pandion Therapeutics, Inc. | 23,622 | reported | 21 Jul 2020 | tx 5+2,131,135−7,184,596 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Oct 2023 | PURCHASE | Tango Therapeutics, Inc. | 750,000 | 7.07 USD | first after silence |
| 16 Oct 2023 | PURCHASE | Tango Therapeutics, Inc. | 500,000 | 6.84 USD | |
| 17 Dec 2021 | PURCHASE | Tyra Biosciences, Inc. | 125,000 | 13.12 USD | |
| 23 Apr 2021 | PURCHASE | Rain Therapeutics Inc. | 25,000 | 15.58 USD | |
| 27 Apr 2021 | PURCHASE | Rain Therapeutics Inc. | 1,025,000 | 17.00 USD | |
| 23 Apr 2021 | PURCHASE | Rain Therapeutics Inc. | 125,000 | 16.27 USD | |
| 27 Apr 2021 | CONVERSION | Rain Therapeutics Inc. | 3,022,489 | 0.00 USD | deriv |
| 27 Apr 2021 | CONVERSION | Rain Therapeutics Inc. | 3,263,986 | 0.00 USD | deriv |
| 28 Dec 2020 | PURCHASE | Odonate Therapeutics, Inc. | 225,000 | 17.11 USD | |
| 30 Dec 2020 | PURCHASE | Odonate Therapeutics, Inc. | 100,000 | 17.46 USD | |
| 28 Dec 2020 | PURCHASE | Odonate Therapeutics, Inc. | 75,000 | 16.90 USD | |
| 25 Sept 2020 | PURCHASE | PMV Pharmaceuticals, Inc. | 950,000 | 18.00 USD | |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 28,129 | — | |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 586,099 | — | |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 732,137 | — | |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 32,708 | — | |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 28,129 | 0.00 USD | deriv |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 732,137 | 0.00 USD | deriv |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 586,099 | 0.00 USD | deriv |
| 29 Sept 2020 | CONVERSION | PMV Pharmaceuticals, Inc. | 32,708 | 0.00 USD | deriv |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 2,943,568 | — | |
| 28 Jul 2020 | PURCHASE | iTeos Therapeutics, Inc. | 23,552 | 19.00 USD | |
| 28 Jul 2020 | PURCHASE | iTeos Therapeutics, Inc. | 1,401,448 | 19.00 USD | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 48,691 | — | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 158,687 | — | deriv |
2 purchases reported after at least 12 months of silence — most recent on 13 Oct 2023.